About Pictor
Pictor is a company based in Auckland (New Zealand) founded in 2005 by Wanda Lee Mathias. It operates as a HealthTech and Product-as-a-Service. Pictor has raised $11.1 million across 5 funding rounds from investors including Marko Bogoievski, K1W1 and Cure Kids Ventures. Pictor offers products and services including PictArray™, PictImager™, and Pictorial™ Software. Pictor operates in a competitive market with competitors including Natera, Curative, BillionToOne, Heska and Progenity, among others.
- Headquarter Auckland, New Zealand
- Founders Wanda Lee Mathias
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pictor Inc.
- Date of Incorporation 03 Aug, 2016
- Jurisdiction Bhiwandi, Maharashtra, India
-
Annual Revenue
$213.22 K (USD)35.36as on Mar 31, 2022
-
Net Profit
$3.04 K (USD)106.85as on Mar 31, 2022
-
EBITDA
$9.91 K (USD)128.64as on Mar 31, 2022
-
Total Equity Funding
$11.1 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
K1W1
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pictor
Pictor offers a comprehensive portfolio of products and services, including PictArray™, PictImager™, and Pictorial™ Software.
Multiplex array testing is provided for various samples.
High-resolution imaging is offered for rapid plate analysis.
Automated data analysis is integrated with lab systems.
Funding Insights of Pictor
Pictor has successfully raised a total of $11.1M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pictor
Pictor has secured backing from 5 investors, including angel and venture fund investors. Prominent investors backing the company include Marko Bogoievski, K1W1 and Cure Kids Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Seed and early-stage investments are made in child health innovations.
|
Locked | Locked | Locked | |
|
Venture capital investments are targeted through managed funds of funds.
|
Locked | Locked | Locked |
Investor details for Pictor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pictor
Investment portfolio details for Pictor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pictor
Detailed financials for Pictor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pictor Comparisons
Peer comparison for Pictor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pictor
Pictor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, Curative, BillionToOne, Heska and Progenity, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Curative is recognized for providing affordable employer-sponsored health insurance.
|
|
| Locked | Locked | Locked |
Provider of cell-free cancer liquid biopsy test
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for pet care
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for IVF embryo viability assessment are developed.
|
Detailed competitors of Pictor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pictor
Complete news archive for Pictor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pictor
Pictor was founded in 2005 and raised its 1st funding round 10 years after it was founded.
Pictor is headquartered in Auckland, New Zealand.
Champak Mehta is the current CEO of Pictor.
Pictor is a funded company, having raised a total of $11.1M across 5 funding rounds to date.
Annual revenue of Pictor is $213.22K as on Mar 31, 2022.
Pictor is focused on delivering accessible multiplex biomarker testing solutions for clinical laboratories, researchers, and veterinary clinics. The company operates in the healthcare and diagnostics sector, specializing in proteomics. Its platform, including PictArray, PictImager, and Pictorial Software, is designed to analyze multiple analytes per sample, supporting deeper biological insights while reducing complexity and costs. Solutions are tailored for routine clinical operations, offering affordability, scalability, and market access for diverse applications across human and animal health. The technology is supported by AI-driven analysis, ensuring efficiency in high-throughput testing environments.
Pictor's top competitors include Natera, BillionToOne and Curative.
Pictor offers PictArray™, PictImager™, and Pictorial™ Software.
Pictor has 5 investors. Key investors include Marko Bogoievski, K1W1, Cure Kids Ventures, New Zealand Growth Capital Partners, and Marko Bogoievski.